nitroblue tetrazolium has been researched along with Cerebrovascular Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kusakabe, T; Nagamine, T; Nakazato, K; Sakurai, H; Suzuki, K; Takatama, M | 1 |
| Armstead, WM; Kulkarni, M | 1 |
| Gusev, EI; Klebanov, GI; Kreĭnina, MV; Kuznetsov, SV; Nifontova, LA | 1 |
3 other study(ies) available for nitroblue tetrazolium and Cerebrovascular Disorders
| Article | Year |
|---|---|
Role of oxidative stress on pathogenesis of hypertensive cerebrovascular lesions.
Topics: Aldehydes; Animals; Arterioles; Brain; Brain Edema; Cerebral Hemorrhage; Cerebrovascular Disorders; Disease Models, Animal; Endothelium, Vascular; Hypertension; Intracranial Arterial Diseases; Male; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroblue Tetrazolium; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Tyrosine; Up-Regulation | 2007 |
Superoxide generation links nociceptin/orphanin FQ (NOC/oFQ) release to impaired N-methyl-D-aspartate cerebrovasodilation after brain injury.
Topics: Animals; Animals, Newborn; Cerebral Arteries; Cerebrovascular Circulation; Cerebrovascular Disorders; Cyclooxygenase Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acids; Female; Indomethacin; Male; N-Methylaspartate; Nitroblue Tetrazolium; Nociceptin; Opioid Peptides; Prostaglandin-Endoperoxide Synthases; Superoxide Dismutase; Vasodilation | 2000 |
[Functional activity of the blood polymorphonuclear leukocytes in vascular lesions of the brain].
Topics: Adult; Aged; Cerebrovascular Disorders; Female; Humans; Hypertension; Intracranial Arteriosclerosis; Luminescent Measurements; Male; Middle Aged; Neutrophils; Nitroblue Tetrazolium; Oxidation-Reduction | 1988 |